GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells

Pigment Cell and Melanoma Research

Volumn 26, Issue 6, 2013, Pages 861-873

  Perrot, Carole Y ^a,b   Gilbert, Cristèle ^a,b   Marsaud, Véronique ^a,b   Postigo, Antonio ^c,d,e   Javelaud, Delphine ^a,b   Mauviel, Alain ^a,b  

^a INSTITUT CURIE   (France)

^b Centre National de la Recherche Scientifique   (France)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

E cadherin; Gene expression; GLI2; Melanoma; ZEB1

Indexed keywords

KRUPPEL LIKE FACTOR; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR ZEB1; UVOMORULIN;

ARTICLE; BINDING SITE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MELANOMA CELL; PROMOTER REGION; RNA EXTRACTION; WESTERN BLOTTING;

E-CADHERIN; GENE EXPRESSION; GLI2; MELANOMA; ZEB1;

BASE SEQUENCE; BINDING SITES; CADHERINS; CELL LINE, TUMOR; CELL NUCLEUS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HOMEODOMAIN PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MELANOMA; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84886298202     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12149     Document Type: Article

References (50)

1. Alexaki, V.I., Javelaud, D., Van Kempen, L.C. et al. (2010). GLI2-mediated melanoma invasion and metastasis. J. Natl Cancer Inst. 102, 1148-1159.
2. Andrews, N.C., and Faller, D.V. (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19, 2499.
3. Barbera, M.J., Puig, I., Dominguez, D. et al. (2004). Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23, 7345-7354.
4. Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J., and Garcia De Herreros, A. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2, 84-89.
5. Berx, G., and Van Roy, F. (2009). Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb. Perspect. Biol. 1, a003129.
6. Cheli, Y., Giuliano, S., Fenouille, N. et al. (2012). Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 31, 2461-2470.
7. Curtin, J.A., Fridlyand, J., Kageshita, T. et al. (2005). Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135-2147.
8. De Craene, B., and Berx, G. (2013). Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97-110.
9. Dennler, S., Andre, J., Alexaki, I., Li, A., Magnaldo, T., Ten Dijke, P., Wang, X.J., Verrecchia, F., and Mauviel, A. (2007). Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 67, 6981-6986.
10. Dennler, S., Andre, J., Verrecchia, F., and Mauviel, A. (2009). Cloning of the human GLI2 promoter: transcriptional activation by transforming growth factor-beta via SMAD3/beta-catenin cooperation. J. Biol. Chem. 284, 31523-31531.
11. Dong, C., Wu, Y., Yao, J., Wang, Y., Yu, Y., Rychahou, P.G., Evers, B.M., and Zhou, B.P. (2012). G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J. Clin. Invest. 122, 1469-1486.
12. Elder, D.E. (2006). Pathology of melanoma. Clin. Cancer Res. 12, 2308s-2311s.
13. Guaita, S., Puig, I., Franci, C., Garrido, M., Dominguez, D., Batlle, E., Sancho, E., Dedhar, S., De Herreros, A.G., and Baulida, J. (2002). Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J. Biol. Chem. 277, 39209-39216.
14. He, S., Wang, F., Yang, L. et al. (2011). Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. PLoS ONE 6, e27684.
15. Heldin, C.H., Vanlandewijck, M., and Moustakas, A. (2012). Regulation of EMT by TGFbeta in cancer. FEBS Lett. 586, 1959-1970.
16. Hoek, K.S., and Goding, C.R. (2010). Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23, 746-759.
17. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290-302.
18. Hsu, M.Y., Meier, F.E., Nesbit, M., Hsu, J.Y., Van Belle, P., Elder, D.E., and Herlyn, M. (2000). E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156, 1515-1525.
19. Hui, C.C., and Angers, S. (2011). Gli proteins in development and disease. Annu. Rev. Cell Dev. Biol. 27, 513-537.
20. Javelaud, D., Mohammad, K.S., Mckenna, C.R. et al. (2007). Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res. 67, 2317-2324.
21. Javelaud, D., Alexaki, V.I., and Mauviel, A. (2008). Transforming growth factor-beta in cutaneous melanoma. Pigment Cell Melanoma Res. 21, 123-132.
22. Javelaud, D., Alexaki, V.I., Pierrat, M.J. et al. (2011a). GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Pigment Cell Melanoma Res. 24, 932-943.
23. Javelaud, D., Van Kempen, L., Alexaki, V.I., Le Scolan, E., Luo, K., and Mauviel, A. (2011b). Efficient TGF-beta/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. Mol. Cancer 10, 2.
24. Javelaud, D., Pierrat, M.J., and Mauviel, A. (2012). Crosstalk between TGF-beta and hedgehog signaling in cancer. FEBS Lett. 586, 2016-2025.
25. Karreth, F.A., Tay, Y., Perna, D. et al. (2011). In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147, 382-395.
26. Li, X., Deng, W., Nail, C.D., Bailey, S.K., Kraus, M.H., Ruppert, J.M., and Lobo-Ruppert, S.M. (2006). Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene 25, 609-621.
27. Li, X., Deng, W., Lobo-Ruppert, S.M., and Ruppert, J.M. (2007). Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin. Oncogene 26, 4489-4498.
28. Lo, R.S., and Witte, O.N. (2008). Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes. Cancer Res. 68, 4248-4257.
29. McConnell, B.B., and Yang, V.W. (2010). Mammalian Kruppel-like factors in health and diseases. Physiol. Rev. 90, 1337-1381.
30. Mill, J., Yazdanpanah, S., Guckel, E., Ziegler, S., Kaminsky, Z., and Petronis, A. (2006). Whole genome amplification of sodium bisulfite-treated DNA allows the accurate estimate of methylated cytosine density in limited DNA resources. Biotechniques 41, 603-607.
31. Mohammad, K.S., Javelaud, D., Fournier, P.G., Niewolna, M., Mckenna, C.R., Peng, X.H., Duong, V., Dunn, L.K., Mauviel, A., and Guise, T.A. (2011). TGF-{beta}-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res. 71, 175-184.
32. Nieto, M.A., Bennett, M.F., Sargent, M.G., and Wilkinson, D.G. (1992). Cloning and developmental expression of Sna, a murine homologue of the Drosophila snail gene. Development 116, 227-237.
33. Peinado, H., Olmeda, D., and Cano, A. (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7, 415-428.
34. Perrot, C.Y., Javelaud, D., and Mauviel, A. (2013a). Insights into the transforming growth factor-β signaling pathway in cutaneous melanoma. Ann. Dermatol. 25, 135-144.
35. Perrot, C.Y., Javelaud, D., and Mauviel, A. (2013b). Overlapping activities of TGF-beta and Hedgehog signaling in cancer: therapeutic targets for cancer treatment. Pharmacol. Ther. 137, 183-199.
36. Pierrat, M.J., Marsaud, V., Mauviel, A., and Javelaud, D. (2012). Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-beta. J. Biol. Chem. 287, 17996-18004.
37. Postigo, A.A., and Dean, D.C. (1997). ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation. EMBO J. 16, 3935-3943.
38. Postigo, A.A., Depp, J.L., Taylor, J.J., and Kroll, K.L. (2003). Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 22, 2453-2462.
39. Roessler, E., Ermilov, A.N., Grange, D.K., Wang, A., Grachtchouk, M., Dlugosz, A.A., and Muenke, M. (2005). A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2. Hum. Mol. Genet. 14, 2181-2188.
40. Sanchez-Tillo, E., Liu, Y., De Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D.S., Dean, D.C., Castells, A., and Postigo, A. (2012). EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell. Mol. Life Sci. 69, 3429-3456.
41. Santini, R., Vinci, M.C., Pandolfi, S. et al. (2012). Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells 30, 1808-1818.
42. Shirakihara, T., Saitoh, M., and Miyazono, K. (2007). Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol. Biol. Cell 18, 3533-3544.
43. Shirley, S.H., Greene, V.R., Duncan, L.M., Torres Cabala, C.A., Grimm, E.A., and Kusewitt, D.F. (2012). Slug expression during melanoma progression. Am. J. Pathol. 180, 2479-2489.
44. Steingrimsson, E., Copeland, N.G., and Jenkins, N.A. (2004). Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet. 38, 365-411.
45. Tsai, J.H., Donaher, J.L., Murphy, D.A., Chau, S., and Yang, J. (2012). Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725-736.
46. Valyi-Nagy, I.T., Hirka, G., Jensen, P.J., Shih, I.M., Juhasz, I., and Herlyn, M. (1993). Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. Lab. Invest. 69, 152-159.
47. Wang, Y., and Shang, Y. (2013). Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Exp. Cell Res. 319, 160-169.
48. Weiss, M.B., Abel, E.V., Mayberry, M.M., Basile, K.J., Berger, A.C., and Aplin, A.E. (2012). TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells. Cancer Res. 72, 6382-6392.
49. Widmer, D.S., Cheng, P.F., Eichhoff, O.M., Belloni, B.C., Zipser, M.C., Schlegel, N.C., Javelaud, D., Mauviel, A., Dummer, R., and Hoek, K.S. (2012). Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res. 25, 343-353.
50. Zavadil, J., and Bottinger, E.P. (2005). TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24, 5764-5774.